FDA approves drug to treat postpartum depression

The U.S. Food and Drug Administration has approved the first drug specifically developed to treat postpartum depression. The agency on Tuesday approved Sage Therapeutics’ Zulresso, a physician administered IV drug given over 2 ½ days. (March 20)

Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Google+: https://plus.google.com/115892241801867723374
Instagram: https://www.instagram.com/APNews/

You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/84d2a6abe6681a534e12d41b878068f7